1
|
Melikyan ZA, Corrada MM, Dick MB, Whittle C, Paganini-Hill A, Kawas CH. Neuropsychological Test Norms in Cognitively Intact Oldest-Old. J Int Neuropsychol Soc 2019; 25:530-545. [PMID: 31122309 PMCID: PMC6538395 DOI: 10.1017/s1355617719000122] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
OBJECTIVES Individuals aged 90 or older (oldest-old), the fastest growing segment of the population, are at increased risk of developing cognitive impairment compared with younger old. Neuropsychological evaluation of the oldest-old is important yet challenging in part because of the scarcity of test norms for this group. We provide neuropsychological test norms for cognitively intact oldest-old. METHODS Test norms were derived from 403 cognitively intact participants of The 90+ Study, an ongoing study of aging and dementia in the oldest-old. Cognitive status of intact oldest-old was determined at baseline using cross-sectional approach. Individuals with cognitive impairment no dementia or dementia (according to DSM-IV criteria) were excluded. Participants ranged in age from 90 to 102 years (mean=94). The neuropsychological battery included 11 tests (Mini-Mental Status Examination, Modified Mini-Mental State Examination, Boston Naming Test - Short Form, Letter Fluency Test, Animal Fluency Test, California Verbal Learning Test-II Short Form, Trail Making Tests A/B/C, Digit Span Forward and Backwards Test, Clock Drawing Test, CERAD Construction Subtests), and the Geriatric Depression Scale. RESULTS Data show significantly lower scores with increasing age on most tests. Education level, sex, and symptoms of depression were associated with performance on several tests after accounting for age. CONCLUSIONS Provided test norms will help to distinguish cognitively intact oldest-old from those with cognitive impairment. (JINS, 2019, 25, 530-545).
Collapse
Affiliation(s)
- Zarui A Melikyan
- 1Institute for Memory Impairments and Neurological Disorders,University of California,Irvine,California
| | - Maria M Corrada
- 1Institute for Memory Impairments and Neurological Disorders,University of California,Irvine,California
| | - Malcolm B Dick
- 1Institute for Memory Impairments and Neurological Disorders,University of California,Irvine,California
| | - Christina Whittle
- 1Institute for Memory Impairments and Neurological Disorders,University of California,Irvine,California
| | | | - Claudia H Kawas
- 1Institute for Memory Impairments and Neurological Disorders,University of California,Irvine,California
| |
Collapse
|
2
|
Legdeur N, Binnekade T, Otten R, Badissi M, Scheltens P, Visser P, Maier A. Cognitive functioning of individuals aged 90 years and older without dementia: A systematic review. Ageing Res Rev 2017; 36:42-49. [PMID: 28284872 DOI: 10.1016/j.arr.2017.02.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2016] [Revised: 02/25/2017] [Accepted: 02/27/2017] [Indexed: 10/20/2022]
Abstract
INTRODUCTION Reference values to define cognitive impairment in individuals aged 90 years and older are lacking. We systematically reviewed the literature to determine the level of cognitive functioning of individuals aged 90 years and older without dementia. METHODS The search identified 3972 articles of which 20 articles were included in the review. We calculated mean cognitive test scores and cut-off scores for cognitive tests published in two or more articles. RESULTS The mean cognitive test scores (SD)/cut-off scores for individuals aged 90 years and older without dementia of the five most commonly used cognitive tests were: MMSE: 26.6 (2.6)/23.3 points, Digit Span forward: 5.9 (1.8)/3.6 digits, Digit Span backward: 4.4 (1.6)/2.4 digits, TMT-A: 85.8 (42.5)/140.2s and TMT-B: 220.3 (99.2)/347.3s. DISCUSSION We provided mean cognitive test scores and cut-off scores that will improve the diagnostic process of cognitive impairment in individuals aged 90 years and older.
Collapse
|
3
|
Luo C, Chen X, Jin H, Yao K. The association between gout and cataract risk: A meta-analysis. PLoS One 2017; 12:e0180188. [PMID: 28662131 PMCID: PMC5491146 DOI: 10.1371/journal.pone.0180188] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2017] [Accepted: 06/12/2017] [Indexed: 01/19/2023] Open
Abstract
PURPOSE To evaluate the relationship between gout and age-related cataracts (ARCs). METHODS A comprehensive literature search of the PubMed and Web of Science databases was conducted to identify papers on the association between gout and cataract risk that had been published between February 1991 and January 2017. Pooled relative risks (RRs) or odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were calculated. The random-effects model was used instead of the fixed-effects model when heterogeneity was identified, as indicated by a Cochran's Q statistic P-value <0.10 or I2 index score >50%. RESULTS A total of 3 cross-sectional studies and 3 case-control studies were included in the meta-analysis. Gout was significantly associated with increased odds of ARCs (OR 1.53, 95% CI 1.27-1.84). In the subgroup analysis, gout exhibited positive associations with the odds of posterior subcapsular cataracts (PSCs, OR 1.69, 95% CI: 1.06-2.70) and cortical cataracts (CCs, OR 1.39, 95% CI: 1.06-1.81). However, no association was identified between gout and the odds of nuclear cataracts. CONCLUSIONS The current literature suggested that gout may be associated with increased odds of ARCs, especially PSCs and CCs. Further efforts should be made to confirm these findings and clarify the effect of gout and gout medications on the development of cataracts.
Collapse
Affiliation(s)
- Chenqi Luo
- Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
| | - Xinyi Chen
- Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
| | - Hongchuan Jin
- Department of Medical Oncology, Key Laboratory of Biotherapy in Zhejiang, Sir Runrun Shaw Hospital, Medical School of Zhejiang University, Hangzhou, China
- * E-mail: (KY); (HJ)
| | - Ke Yao
- Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
- * E-mail: (KY); (HJ)
| |
Collapse
|
5
|
Babizhayev MA, Vishnyakova KS, Yegorov YE. Hormone-brain-aging relationships, broadly reactive with imidazole-containing dipeptides: targeting of telomere attrition as an aging biomarker and dynamic telomerase activity flirting. J Basic Clin Physiol Pharmacol 2014; 26:115-40. [PMID: 25153587 DOI: 10.1515/jbcpp-2014-0045] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2014] [Accepted: 05/10/2014] [Indexed: 11/15/2022]
Abstract
It has been documented that telomere-associated cellular senescence may contribute to certain age-related disorders, and telomere length (TL) may be an informative biomarker of healthy aging. Hormone-brain-aging behavior-modulated telomere dynamics and changes in telomerase activity are consistent elements of cellular alterations associated with changes in proliferative state, and these processes are consequently considered as the new therapeutic drug targets for physiological control with advanced drug delivery and nutritional formulations. We raise and support a therapeutic concept of using nonhydrolyzed forms of naturally occurring neuron-specific imidazole dipeptide-based compounds carnosine and carcinine, making it clinically possible that slowing down the rate of telomere shortening could slow down the human aging process in specific tissues where proliferative senescence is known to occur, with the demonstrated evidence of telomere shortening that appeared to be a hallmark of oxidative stress and disease. Carnosine released from skeletal muscle during exercise may be transported into the hypothalamic tuberomammillary nucleus (TMN) histamine neurons and hydrolyzed. The resulting L-histidine may subsequently be converted into histamine, which could be responsible for the effects of carnosine on neurotransmission and hormone-like antiaging physiological function. The preliminary longitudinal studies of elderly individuals suggest that longer telomeres are associated with better survival, and an advanced oral nutritional support with nonhydrolyzed carnosine (or carcinine and patented compositions thereof) is a useful therapeutic tool for a critical TL maintenance that may fundamentally be applied in the treatment of age-related sight-threatening eye disorders, prolonged life expectancy, increased survival and chronological age of an organism in health control, smoking behavior, and disease. "Our pleasures were simple-they included survival." -Dwight D. Eisenhower, 34th President of the United States, 1953-1961.
Collapse
|
6
|
Urfer SR, Greer K, Wolf NS. Age-related cataract in dogs: a biomarker for life span and its relation to body size. AGE (DORDRECHT, NETHERLANDS) 2011; 33:451-460. [PMID: 20607428 PMCID: PMC3168595 DOI: 10.1007/s11357-010-9158-4] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2010] [Accepted: 06/14/2010] [Indexed: 05/29/2023]
Abstract
Clinical data from 72 dog breeds of varying size and life expectancy were grouped according to breed body mass and tested for prevalence at ages 4 to 5, ages 7 to 10, and lifetime incidence of non-hereditary, age-related cataract (ARC). The incidence of ARC was found to be directly related to the relative life expectancies in the breed groups: The smallest dog breeds had a lower ARC prevalence between ages 4 and 5 than mid-size breeds and these, in turn, a lower prevalence than the giant breeds. A similar sequence was evident for ages 7 to 10 and for overall lifetime incidence of ARC. These differences became more significant when comparing small and giant breeds only. We could also confirm the inverse relationship between body size and life expectancy in these same sets of dog breeds. Our results show that body size, life expectancy, and ARC incidence are interrelated in dogs. Given that ARC has been shown to be at least partially caused by oxidative damage to lens epithelial cells and the internal lens, we suggest that it can be considered not only as a general biomarker for life expectancy in the canine and possibly other species, but also for the systemic damages produced by reactive oxygen species. This suggests new approaches to examine the gene expression pathways affecting the above-noted linkages.
Collapse
Affiliation(s)
- Silvan R. Urfer
- Department of Pathology, University of Washington, Seattle, WA 98195-7470 USA
| | - Kimberly Greer
- School of Natural Sciences and Mathematics, Indiana University East, Richmond, IN 47374 USA
| | - Norman S. Wolf
- Department of Pathology, University of Washington, Seattle, WA 98195-7470 USA
| |
Collapse
|
7
|
Zhu X, Korlimbinis A, Truscott RJ. Age-Dependent Denaturation of Enzymes in the Human Lens: A Paradigm for Organismic Aging? Rejuvenation Res 2010; 13:553-60. [DOI: 10.1089/rej.2009.1009] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Affiliation(s)
- Xiangjia Zhu
- Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China
- Save Sight Institute, University of Sydney, NSW, 2001, Australia
| | | | | |
Collapse
|
8
|
Jun G, Guo H, Klein BEK, Klein R, Wang JJ, Mitchell P, Miao H, Lee KE, Joshi T, Buck M, Chugha P, Bardenstein D, Klein AP, Bailey-Wilson JE, Gong X, Spector TD, Andrew T, Hammond CJ, Elston RC, Iyengar SK, Wang B. EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet 2009; 5:e1000584. [PMID: 19649315 PMCID: PMC2712078 DOI: 10.1371/journal.pgen.1000584] [Citation(s) in RCA: 117] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2009] [Accepted: 07/02/2009] [Indexed: 12/13/2022] Open
Abstract
Age-related cataract is a major cause of blindness worldwide, and cortical cataract is the second most prevalent type of age-related cataract. Although a significant fraction of age-related cataract is heritable, the genetic basis remains to be elucidated. We report that homozygous deletion of Epha2 in two independent strains of mice developed progressive cortical cataract. Retroillumination revealed development of cortical vacuoles at one month of age; visible cataract appeared around three months, which progressed to mature cataract by six months. EPHA2 protein expression in the lens is spatially and temporally regulated. It is low in anterior epithelial cells, upregulated as the cells enter differentiation at the equator, strongly expressed in the cortical fiber cells, but absent in the nuclei. Deletion of Epha2 caused a significant increase in the expression of HSP25 (murine homologue of human HSP27) before the onset of cataract. The overexpressed HSP25 was in an underphosphorylated form, indicating excessive cellular stress and protein misfolding. The orthologous human EPHA2 gene on chromosome 1p36 was tested in three independent worldwide Caucasian populations for allelic association with cortical cataract. Common variants in EPHA2 were found that showed significant association with cortical cataract, and rs6678616 was the most significant in meta-analyses. In addition, we sequenced exons of EPHA2 in linked families and identified a new missense mutation, Arg721Gln, in the protein kinase domain that significantly alters EPHA2 functions in cellular and biochemical assays. Thus, converging evidence from humans and mice suggests that EPHA2 is important in maintaining lens clarity with age. Cataract is the leading cause of blindness. Cataract may form at any age, but the peak incidence is bimodal—in the perinatal period or later than 50 years of age. The early onset forms follow Mendelian inheritance patterns and are rare. Age-related cataract accounts for 18 million cases of blindness and 59 million cases of reduced vision worldwide. Among three types of age-related cataract, cortical cataract is known to be highly heritable, although few genes have been linked to its etiology. We report here that EPHA2 is associated with cortical cataract. EPHA2 is expressed in mouse and human cortical lens fiber cells, and homozygous deletion of Epha2 in two independent strains of mice led to development of cataract that progressed with age. Common and rare variants including a missense mutation in the EPHA2 gene were associated for cortical cataract in three different Caucasian populations. Our study identified EPHA2 as a gene for human age-related cataract and established Epha2 knockout mice as a model for progressive cortical cataract.
Collapse
MESH Headings
- Age Factors
- Aged
- Animals
- Cataract/genetics
- Cataract/metabolism
- Cataract/pathology
- Chromosomes, Human, Pair 1/genetics
- Cohort Studies
- Disease Models, Animal
- Female
- Humans
- Lens, Crystalline/chemistry
- Lens, Crystalline/metabolism
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Middle Aged
- Molecular Sequence Data
- Mutation
- Polymorphism, Single Nucleotide
- Protein Structure, Tertiary
- Receptor, EphA2/chemistry
- Receptor, EphA2/genetics
- Receptor, EphA2/metabolism
- Sequence Alignment
- Visual Cortex/chemistry
- Visual Cortex/metabolism
- White People/genetics
Collapse
Affiliation(s)
- Gyungah Jun
- Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Hong Guo
- Rammelkamp Center for Research, Department of Pharmacology and Ireland Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Barbara E. K. Klein
- Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Ronald Klein
- Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Jie Jin Wang
- Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, Department of Ophthalmology, University of Sydney, Sydney, Australia
- Centre for Eye Research Australia and Department of Ophthalmology, University of Melbourne, Melbourne, Australia
| | - Paul Mitchell
- Centre for Vision Research, Westmead Millennium Institute, Westmead Hospital, Department of Ophthalmology, University of Sydney, Sydney, Australia
| | - Hui Miao
- Rammelkamp Center for Research, Department of Pharmacology and Ireland Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Kristine E. Lee
- Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America
| | - Tripti Joshi
- Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Matthias Buck
- Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Preeti Chugha
- Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - David Bardenstein
- Ocular Oncology Service, Department of Ophthalmology and Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Alison P. Klein
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
| | - Joan E. Bailey-Wilson
- Inherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Xiaohua Gong
- School of Optometry and Vision Science Program, University of California Berkeley/University of California San Francisco Joint Bioengineering Graduate Program, University of California Berkeley, Berkeley, California, United States of America
| | - Tim D. Spector
- King's College London, St Thomas' Hospital Campus, Twin Research and Genetic Epidemiology Unit, London, United Kingdom
| | - Toby Andrew
- King's College London, St Thomas' Hospital Campus, Twin Research and Genetic Epidemiology Unit, London, United Kingdom
| | - Christopher J. Hammond
- King's College London, St Thomas' Hospital Campus, Twin Research and Genetic Epidemiology Unit, London, United Kingdom
| | - Robert C. Elston
- Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
| | - Sudha K. Iyengar
- Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
- Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
- Department of Ophthalmology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
- * E-mail: (SKI); (BW)
| | - Bingcheng Wang
- Rammelkamp Center for Research, Department of Pharmacology and Ireland Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America
- * E-mail: (SKI); (BW)
| |
Collapse
|
9
|
Wong TY, Hyman L. Population-based studies in ophthalmology. Am J Ophthalmol 2008; 146:656-63. [PMID: 18984085 DOI: 10.1016/j.ajo.2008.07.048] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2008] [Revised: 07/27/2008] [Accepted: 07/29/2008] [Indexed: 01/13/2023]
Abstract
PURPOSE To review major findings of population-based studies in ophthalmology, to summarize key questions, and to highlight future directions for this study design. DESIGN Summary and critical analysis of major population-based studies in eye diseases. METHODS Literature review and interpretation. RESULTS In the last 30 years, there have been many population-based studies in ophthalmology conducted in the United States and other countries around the world. These studies have provided information on the epidemiology of visual loss and the major eye diseases associated with visual loss; the risk factors; and the socioeconomic burden of eye disease. Population-based studies remain the most valid to determine the prevalence and incidence of a disease, and the population-attributable risk of new risk factors, including the interaction of genetic markers with systemic and environmental factors. Repeated surveys over time may also demonstrate impact of preventive strategies. CONCLUSIONS Population-based studies have provided substantial data on the frequency and impact of the major eye diseases in the community. This study design will continue to have an important role in addressing key questions of why eye diseases occur, who is at highest risk, and what preventive and therapeutic strategies are necessary to eliminate these diseases.
Collapse
|